Hyperthermic intraperitoneal chemoperfusion in combined treatment of locally advanced and disseminated gastric cancer: Results of a single-centre retrospective study

International Journal of Hyperthermia

Volumn 30, Issue 3, 2014, Pages 159-165

  Yarema, Roman Romanovych ^a   Ohorchak, Myron A ^b   Zubarev, Gennadyi P ^b   Mylyan, Yuriy P ^b   Oliynyk, Yuriy Y ^a   Zubarev, Mykola G ^a   Gyrya, Petro I ^b   Kovalchuk, Yuriy J ^b   Safiyan, Victor I ^b   Fetsych, Taras G ^a  

^a DANYLO HALYTSKY LVIV NATIONAL MEDICAL UNIVERSITY   (Ukraine)

^b Lviv Cancer Center   (Ukraine)

Author keywords

Cytoreductive operation; Gastric cancer; Hyperthermic intraperitoneal chemoperfusion; Peritoneal carcinomatosis

Indexed keywords

CAPECITABINE PLUS OXALIPLATIN; CISPLATIN; FLUOROURACIL; MITOMYCIN; TEGAFUR; ANTINEOPLASTIC AGENT;

ACUTE HEMORRHAGIC PANCREATITIS; ADULT; ADVANCED CANCER; AGED; ARTICLE; ATHEROSCLEROSIS; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER PALLIATIVE THERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; DISSEMINATED CANCER; FEMALE; FOLLOW UP; GASTRECTOMY; HUMAN; HYPERTHERMIC INTRAPERITONEAL CHEMOPERFUSION; HYPERTHERMIC THERAPY; LAPAROTOMY; LENGTH OF STAY; MALE; MULTIMODALITY CANCER THERAPY; POSTOPERATIVE COMPLICATION; QUALITY OF LIFE; RETROSPECTIVE STUDY; SEPSIS; STOMACH CANCER; SURVIVAL RATE; TREATMENT DURATION; CLINICAL TRIAL; MIDDLE AGED; PATHOLOGY; STOMACH NEOPLASMS; YOUNG ADULT;

ADULT; AGED; ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; YOUNG ADULT;

EID: 84899743629     PISSN: 02656736     EISSN: 14645157     Source Type: Journal    
DOI: 10.3109/02656736.2014.893451     Document Type: Article

References (22)

1. Elias D, Gilly F, Quenet F, Bereder JM, Sidéris L, Mansvelt B, et al. Pseudomyxoma peritonei: A French multicentric study of 301 patients treated with cytoreductive surgery and intraperitoneal chemotherapy. Eur J Surg Oncol 2010;36:456-62.
2. Baratti D, Scivales A, Balestra MR, Ponzi P, DiStasi F, Kusamura S, et al. Cost analysis of the combined procedure of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). Eur J Surg Oncol 2010;36:463-9.
3. Sommariva A, Pilati P, Rossi CR. Cytoreductive surgery combined with hyperthermic intra-peritoneal chemotherapy for peritoneal surface malignancies: Current treatment and results. Cancer Treat Rev 2012;38:258-68.
4. Sugarbaker PH. Surgical responsibilities in the management of peritoneal carcinomatosis. J SurgOncol 2010;101:713-24.
5. Nissan A, Garofalo A, Esquivel J. Cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy (HIPEC) for gastric adenocarcinoma: Why haven't we reached the promised land? J Surg Oncol 2010;102:359-60.
6. Yatsenko LD. Peculiarities of stage IV metastatic gastric cancer. Oncology (Ukraine) 2007;9:139-44.
7. Bando E, Yonemura Y, Takeshita Y, Taniguchi K, Yasui T, Yoshimitsu Y, et al. Intraoperative lavage for cytological examination in 1297 patients with gastric carcinoma. Am J Surg 1999;178:256-62.
8. Yoo CH, Noh SH, Shin DW, Choi SH, Min JS. Recurrence following curative resection for gastric carcinoma. Br J Surg 2000; 87:236-42.
9. Macdonald JS. Advances in the management of gastric cancer. New York: CMP Medica, 2006.
10. Sobin LH, Gospodarowicz MK, Wittekind C. TNM Classification of Malignant Tumours, 7th edition. Chichester: Wiley-Blackwell, 2010.
11. Bang YJ, Van Cutsem E, Feyereislova A, Chung HC, Shen L, Sawaki A, et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-esophageal junction cancer (ToGA): A phase 3, open-label, randomised controlled trial. Lancet 2010;376:687-97.
12. Hermans J, Bonenkamp JJ, Boon MC, Bunt AM, Ohyama S, Sasako M, et al. Adjuvant therapy after curative resection for gastric cancer: Meta-Analysis of randomized trials. J Clin Oncol 1993;11: 1441-7.
13. Janunger KG, Hafstrom L, Glimelius B. Chemotherapy in gastric cancer: A review and updated meta-Analysis. Eur J Surg 2002;168: 597-608.
14. Japanese Gastric Cancer Association. Japanese classification of gastric cancer, 2nd ed. Gastric Cancer 1998;1:10-24.
15. Sugarbaker PH. Management of peritoneal-surface malignancy: The surgeon's role. Langenbeck's Arch Surg 1999;384:576-87.
16. Cassidy J, Bissett D, Spence R, Payne M. Oxford Handbook of Oncology, 3rd ed. Oxford: Oxford University Press, 2010.
17. Xu DZ, Zhan YQ, Sun XW, Cao SM, Geng OR. Meta-Analysis of intraperitoneal chemotherapy for gastric cancer. World J Gastroenterol 2004;10:2727-30.
18. Yan TD, Black D, Sugarbaker PH, Zhu J, Yonemura Y, Petrou G, et al. A systematic review and meta-Analysis of the randomized controlled trials on adjuvant intraperitoneal chemotherapy for respectable gastric cancer. Ann Surg Oncol 2007;14:2702-13.
19. Mi DH, Li Z, Yang KH, Cao N, Lethaby A, Tian JH, et al. Surgery combined with intraoperative hyperthermic intraperitoneal chemotherapy (IHIC) for gastric cancer: A systematic review and metaanalysis of randomised controlled trials. Int J Hyperthermia 2013; 29:156-67.
20. Sugarbaker PH. Laboratory and clinical basis for hyperthermia as a component of intracavitary chemotherapy. Int J Hypertherm 2007; 23:431-42.
21. Yonemura Y, Fujimura T, Nishimura G, Falla R, Sawa T, Katayama K, et al. Effects of intraoperative chemohyperthermia in patients with gastric cancer with peritoneal dissemination. Surgery 1996; 119:437-44.
22. Glehen O, Gilly FN, Arvieux C, Cotte E, Boutitie F, Mansvelt B, et al. Peritoneal carcinomatosis from gastric cancer: A multiinstitutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy. Ann Surg Oncol 2010;17:2370-7.